Chapel Hill, NC, United States of America

Tatiana D Sotnikova

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2009-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Inventor Tatiana D Sotnikova

Introduction:

Tatiana D Sotnikova is a brilliant female inventor hailing from Chapel Hill, NC, USA, known for her exceptional contributions in the field of pharmaceutical research and development. With a total of 4 patents under her belt, Sotnikova's work is centered around methods for identifying compounds that regulate β-Arrestin signaling complexes.

Latest Patents:

Sotnikova's latest patents focus on innovative methods for screening candidate compounds for β-Arrestin-mediated anti-G protein-coupled receptor signaling activity. These patents describe a meticulous process of contacting the candidate compound to a β-Arrestin signaling complex and detecting any disruption, indicating the compound's activity. Additionally, she has detailed compositions and kits essential for carrying out these groundbreaking methods.

Career Highlights:

Currently affiliated with Duke University, Sotnikova's expertise shines through her research and patent developments. Her work demonstrates a deep understanding of pharmacology and molecular biology, showcasing her dedication to advancing scientific knowledge in drug discovery and development.

Collaborations:

In her professional journey, Sotnikova has had the pleasure of collaborating with esteemed colleagues such as Marc G Caron and Martin Beaulieu. These collaborations have undoubtedly enriched her work, leading to innovative solutions and advancements in the pharmaceutical industry.

Conclusion:

Inventor Tatiana D Sotnikova's remarkable contributions in the realm of pharmaceutical research exemplify her unwavering commitment to innovation and scientific exploration. Her patents stand as a testament to her ingenuity and expertise, shaping the landscape of drug discovery and signaling pathways within the field of pharmacology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…